0      0

Innovative Vaccine Approaches | EK50


Study of SARS-CoV-2 adjuvanted by OMVs as a vaccine platform and future perspectives


Jun 28, 2021 12:00am ‐ Jun 28, 2021 12:00am

Speaker(s):

You must be logged in and own this session in order to post comments.

Print Certificate
Completed on: token-completed_on
Print Transcript
Please select the appropriate credit type:
Number of hours attended:
/
test_id: 
credits: 
completed on: 
rendered in: 
* - Indicates answer is required.
token-content

token-speaker-name
token-index
token-content
token-index
token-content
token-index
token-content
token-index
token-content
token-index
token-content
token-index
token-content
/
/
token-index
token-content
token-index
token-content